期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Crohn's disease presenting as acute gastrointestinal hemorrhage 被引量:4
1
作者 Amareshwar Podugu kanwarpreet tandon Fernando J Castro 《World Journal of Gastroenterology》 SCIE CAS 2016年第16期4073-4078,共6页
Severe gastrointestinal(GI) hemorrhage is a rare complication of Crohn's disease(CD). Although several surgical and non-surgical approaches have been described over the last 2 decades this complication still poses... Severe gastrointestinal(GI) hemorrhage is a rare complication of Crohn's disease(CD). Although several surgical and non-surgical approaches have been described over the last 2 decades this complication still poses significant diagnostic and therapeutic challenges. Given the relative infrequency of severe bleeding in CD, available medical literature on this topic is mostly in the form of retrospective case series and reports. In this article we review the risk factors, diagnostic modalities and treatment options for the management of CD presenting as GI hemorrhage. 展开更多
关键词 Crohn’s disease RECURRENCE GASTROINTESTINAL HEMORRHAGE BIOLOGIC AGENTS Risk factors
下载PDF
Body mass index and colon cancer screening:The road ahead 被引量:4
2
作者 kanwarpreet tandon Mohamad Imam +1 位作者 Bahaa Eldeen Senousy Ismail Fernando Castro 《World Journal of Gastroenterology》 SCIE CAS 2015年第5期1372-1376,共5页
Screening for colorectal cancer(CRC) has been associated with a decreased incidence and mortality from CRC.However,patient adherence to screening is less than desirable and resources are limited even indeveloped count... Screening for colorectal cancer(CRC) has been associated with a decreased incidence and mortality from CRC.However,patient adherence to screening is less than desirable and resources are limited even indeveloped countries.Better identification of individuals at a higher risk could result in improved screening efforts.Over the past few years,formulas have been developed to predict the likelihood of developing advanced colonic neoplasia in susceptible individuals but have yet to be utilized in mass screening practices.These models use a number of clinical factors that have been associated with colonic neoplasia including the body mass index(BMI).Advances in our understanding of the mechanisms by which obesity contributes to colonic neoplasia as well as clinical studies on this subject have proven the association between BMI and colonic neoplasia.However,there are still controversies on this subject as some studies have arrived at different conclusions on the influence of BMI by gender.Future studies should aim at resolving these discrepancies in order to improve the efficiency of screening strategies. 展开更多
关键词 BODY MASS index COLORECTAL CANCER COLON CANCER scr
下载PDF
Endoscopic botox injections in therapy of refractory gastroparesis 被引量:3
3
作者 Andrew Ukleja kanwarpreet tandon +1 位作者 Kinchit Shah Alicia Alvarez 《World Journal of Gastrointestinal Endoscopy》 CAS 2015年第8期790-798,共9页
Gastroparesis(GP) is a common disease seen in gastroenterology practice particularly in western countries, and it may be underdiagnosed. The available drug therapies for this condition are quite disappointing. Botulin... Gastroparesis(GP) is a common disease seen in gastroenterology practice particularly in western countries, and it may be underdiagnosed. The available drug therapies for this condition are quite disappointing. Botulinum toxin type A(BT) has been found to be effective therapy in various spastic disorders of smooth muscle of gastrointestinal tract. However, the benefits of BT injections in GP have been unclear. Several retrospective and open label studies have shown clinical advantages of intrapyloric Botulinum toxin type A injections, while two small randomized trials did not show positive results. Therefore, the available published studies yielded conflicting results leading to fading out of botox therapy for GP. We recognize possible clinical benefit of BT injections without any disadvantages of this treatment. We are calling for revisiting the endoscopy guided botox therapy in refractory GP. In this review we discuss important features of these studies pointing out differences in results among them. Differences in patient selection, doses and method of administration of botox toxin in the prior studies may be the cause of conflicting results. The mechanism of action, indications, efficacy and side-effects of BT are reviewed. Finally, we recognize limited evidence to recommend BT in GP and calling attention for future research in this field since no advances in drug management had been made in the last two decades. 展开更多
关键词 GASTROPARESIS Delayed gastric EMPTYING BOTOX BOTULINUM toxin REFRACTORY GASTROPARESIS
下载PDF
From hepatitis A to E:A critical review of viral hepatitis 被引量:2
4
作者 Daniel Castaneda Adalberto Jose Gonzalez +2 位作者 Mohammad Alomari kanwarpreet tandon Xaralambos Bobby Zervos 《World Journal of Gastroenterology》 SCIE CAS 2021年第16期1691-1715,共25页
Viral infections affecting the liver have had an important impact on humanity,as they have led to significant morbidity and mortality in patients with acute and chronic infections.Once an unknown etiology,the discover... Viral infections affecting the liver have had an important impact on humanity,as they have led to significant morbidity and mortality in patients with acute and chronic infections.Once an unknown etiology,the discovery of the viral agents triggered interest of the scientific community to establish the pathogenesis and diagnostic modalities to identify the affected population.With the rapid scientific and technological advances in the last centuries,controlling and even curing the infections became a possibility,with a large focus on preventive medicine through vaccination.Hence,a comprehensive understanding of hepatitis A,B,C,D and E is required by primary care physicians and gastroenterologists to provide care to these patients.The review article describes the epidemiology,pathogenesis,clinical presentation,diagnostic tools and current medication regimens,with a focus on upcoming treatment options and the role of liver transplantation. 展开更多
关键词 Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E TREATMENT
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部